Teriparatide
CAS 52232-67-4 14 FDA-DMF suppliersPeptide
Overview
Teriparatide is a recombinant form of parathyroid hormone used in the treatment of osteoporosis. It works by stimulating bone formation, increasing bone mineral density and maintaining bone structure.
Therapeutic areas
OsteoporosisEndocrinologyOrthopedics
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.